Effect of 6-months’ vitamin D supplementation on residual beta cell function in children with type 1 diabetes: a case control interventional study
- 5 August 2015
- journal article
- research article
- Published by Walter de Gruyter GmbH in Journal of Pediatric Endocrinology and Metabolism
- Vol. 29 (4) , 395-400
Abstract
Background: The aim of this study was to evaluate the effect of short-term vitamin D supplementation on the decline of residual beta cell function (RBCF) in children with type 1 diabetes (T1D). Methods: The study involved an intervention group (cholecalciferol 2000 IU/day and calcium 25 mg/kg/day for 6 months) comprising 15 children aged 6–12 years and within 1–2 years of diagnosis of T1D. Fifteen age-matched T1D patients were followed up as controls. Stimulated C-peptide levels were estimated at baseline and 6 months. Results: The mean decrease in stimulated C-peptide levels in the intervention group was lower (–0.048±0.15 ng/mL) as compared with the controls (–0.107±0.23 ng/mL) but did not reach statistical significance (p=0.472). The percent decrease in stimulated C-peptide from baseline to endpoint (8.3% vs. 20.3%, p=0.357) and the monthly decrease (0.008 ng/mL vs. 0.017 ng/mL, p=0.22) were non-significantly lower in the intervention group compared with the control group. Three (20%) patients progressed to undetectable stimulated C-peptide (≤0.01 ng/mL) over the study period in the control group as compared with one (6%) in the intervention group (p-value 0.260). Conclusions: There was a trend towards lesser decline of RBCF with short term cholecalciferol supplementation in children with T1D. Further larger studies are urgently needed to explore the beneficial effects of the relatively inexpensive vitamin D supplementation on RBCF.Keywords
This publication has 29 references indexed in Scilit:
- The Role of Vitamin D Deficiency in the Incidence, Progression, and Complications of Type 1 Diabetes MellitusInternational Journal of Endocrinology, 2013
- Improved Preservation of Residual Beta Cell Function by Atorvastatin in Patients with Recent Onset Type 1 Diabetes and High CRP Levels (DIATOR Trial)PLOS ONE, 2012
- Type 1 Diabetes: Etiology, Immunology, and Therapeutic StrategiesPhysiological Reviews, 2011
- Glycemic changes after vitamin D supplementation in patients with type 1 diabetes mellitus and vitamin D deficiencyAnnals of Saudi Medicine, 2010
- No Protective Effect of Calcitriol on β-Cell Function in Recent-Onset Type 1 DiabetesDiabetes Care, 2010
- No Effect of the 1α,25-Dihydroxyvitamin D3 on β-Cell Residual Function and Insulin Requirement in Adults With New-Onset Type 1 DiabetesDiabetes Care, 2010
- Protective effects of 1‐α‐hydroxyvitamin D3 on residual β‐cell function in patients with adult‐onset latent autoimmune diabetes (LADA)Diabetes/Metabolism Research and Reviews, 2009
- Frequency of fokI and taqI polymorphism of vitamin D receptor gene in Indian population and its association with 25-hydroxyvitamin D levelsIndian Journal of Human Genetics, 2009
- Metabolic Factors Affecting Residual Beta Cell Function Assessed by C-Peptide Secretion in Patients with Newly Diagnosed Type 1 DiabetesHormone and Metabolic Research, 2006
- β-Cell Function and the Development of Diabetes-Related Complications in the Diabetes Control and Complications TrialDiabetes Care, 2003